Overview

Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D

Status:
Recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to generate effectiveness data of ARNI, in the Chinese HFrEF patients with implanted ICD or CRT-D. This will be a multicenter, interventional, open-label, and prospective single-arm study to evaluate the effect of ARNI on VAs in approximately 275 HFrEF patients receiving ICD or CRT-D in China.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis Pharmaceuticals